Document and Entity Information Document Information [Table] Class of Stock [Axis] Class of Stock [Domain] Common Class A [Member] Class A common shares Class A Common Shares Classification of common stock representing ownership interest in a corporation. Common Shares [Member] Common shares Common Shares Document Information [Line Items] Document Type Document Quarterly Report Document Period End Date Current Fiscal Year End Date Document Transition Report Securities Act File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Balance Sheets Statement [Table] Statement Assets [Abstract] ASSETS Assets, Current [Abstract] Current Assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Other Receivables, Net, Current Other receivables Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Assets Total Assets Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities, Current [Abstract] Current Liabilities: Accounts Payable and Accrued Liabilities, Current Total accounts payable and accrued expenses Accounts payable and accrued expenses Other Liabilities, Current Payables and accrued expenses - related party Other Liability, Current, Related Party [Extensible Enumeration] Liabilities, Current Total current liabilities Deferred Income, Noncurrent Deferred income Liabilities Total Liabilities Commitments and Contingencies. Commitments and Contingencies (Note 8) Equity, Attributable to Parent [Abstract] Stockholders' Equity Preferred Stock, Value, Issued Preferred stock ($0.0001 par value), 2,000,000 shares authorized, 250,000 shares of Class A preferred stock issued and outstanding as of March 31, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Common stock Common Stock, Value, Subscriptions Common stock issuable, zero and 278,385 shares as of March 31, 2026 and December 31, 2025, respectively Additional Paid in Capital, Common Stock Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Equity, Attributable to Parent Balances Balances Total Stockholders' Equity Liabilities and Equity Total Liabilities and Stockholders' Equity Preferred Stock, Par or Stated Value Per Share Preferred stock par value (in dollars per share) Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Common Stock, Par or Stated Value Per Share Common stock par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Common Stock, Shares Subscribed but Unissued Common stock, shares issuable Statements of Operations Operating Expenses [Abstract] Operating expenses: Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Research and Development Expense (Excluding Acquired in Process Cost), Net Research and development General and Administrative Expense General and administrative Operating Expenses Total operating expenses Operating Income (Loss) Loss from operations Nonoperating Income (Expense) [Abstract] Other income Interest Income, Other Interest income, net Nonoperating Income (Expense) Total other income Net loss Net Loss Earnings Per Share, Basic Net loss per Class A common and common shares outstanding, basic Earnings Per Share, Diluted Net loss per Class A common and common shares outstanding, diluted Weighted Average Number of Shares Outstanding, Basic Weighted average number of Class A common and common shares outstanding, basic Weighted Average Number of Shares Outstanding, Diluted Weighted average number of Class A common and common shares outstanding, diluted Statements of Stockholders' Equity (Deficit) Preferred Class A [Member] Class A preferred shares Equity Components [Axis] Equity Component [Domain] Preferred Stock [Member] Preferred Stock Common Stock [Member] Common Shares Common Stock Issuable [Member] Common Stock Issuable Additional Paid-in Capital [Member] Additional Paid-in Capital Retained Earnings [Member] Accumulated Deficit Shares, Outstanding Balances (in shares) Balances (in shares) The Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. Stock Issued During Period Value Issued For Founders Agreement Issuance of common shares - Annual Stock Dividend Stock Issued During Period, Shares, Issued for Services Shares issued for services (in shares) Issuance of common shares - Annual Stock Dividend (in shares) Value of number of shares issued at equity market offering. Stock Issued During Period Value Equity Fee On At Market Offering Issuance of common shares, equity fee on At-the-Market and equity offerings Common Shares issued equity fee on the market offering. Stock Issued During Period Shares ,Equity Fee On At The Market Offering Issuance of common shares, equity fee on At-the-Market and equity offerings (in shares) Equity impact of the value of new stock issued during the period under equity offering. Stock Issued During Period, Value, Equity Offering Issuance of common shares, net of offering costs - Equity Offerings Number of new stock issued during the period under equity offering. Stock Issued During Period, Shares, Equity Offering Issuance of common shares, net of offering costs - Equity Offerings (in shares) Value of stock issued at the market offering Stock Issued During Period Value, At The Marketing Offering Issuance of common shares, net of offering costs - At-the-Market Offering Number of shares issued at the market offering Stock Issued During Period Shares , At The Market Offering Issuance of common shares, net of offering costs - At-the-Market Offering (in shares) Stock Issued During Period, Value, Employee Stock Purchase Plan Issuance of common shares under ESPP Stock Issued During Period, Shares, Employee Stock Purchase Plans Issuance of common shares under ESPP (in shares) Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Stock-based compensation expenses Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Stock-based compensation expenses (in shares) Number of abeyance shares released during the period. Abeyance Shares Released Abeyance Shares released (in shares) The value of shares issued on exercise of warrants. Share Issued During Period, Value, On Exercise Of Warrants Exercise of warrants The number of shares issued on exercise of warrants. Share Issued During Period, Shares, On Exercise Of Warrants Exercise of warrants (in shares) The amount of additions (reductions) to additional paid-in capital during the period attributable to reverse stock splits. Additions (Reductions) To Additional Paid In Capital, Reverse Stock Splits Reverse Split (1-for-50) adjustment Number of shares attributable to reverse stock split. Number of Shares, Reverse Stock Split Reverse Split (1-for-50) adjustment (in shares) Stockholders' Equity Note, Stock Split, Conversion Ratio Reverse split ratio Statements of Cash Flows Net Cash Provided by (Used in) Operating Activities [Abstract] Cash Flows from Operating Activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Amount of equity fee on equity offering for issuance of common shares. Issuance of Common Shares Equity Fee on Equity Offering Issuance of common shares - equity fee on equity offerings to Fortress Biotech Share-Based Payment Arrangement, Noncash Expense Total stock-based compensation expense Stock-based compensation expenses Depreciation Depreciation expense Operating Lease, Right-of-Use Asset, Periodic Reduction Amortization of operating lease right-of-use assets Amount of payables settled that result in no cashflow. Noncash Settlement Of Payables Settlement of payables Amount of gain (loss) on modification of lease before expiration of lease term. Gain on lease modification Gain on lease termination Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other assets Increase (Decrease) in Other Receivables Other receivables The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid excluding those attributable to related parties. Increase (Decrease) In Accounts Payable And Accrued Expenses Excluding Amounts Due To Related Parties Accounts payable and accrued expenses Increase (Decrease) in Due to Related Parties Payable and accrued expenses - related party Amount of Increase Decrease In Lease Liabilities. Increase Decrease In Lease Liabilities Lease liabilities Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash Flows from Investing Activities: Proceeds from Sale of Property, Plant, and Equipment Proceeds from the sale of property and equipment Net Cash Provided by (Used in) Investing Activities Net cash from investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash Flows from Financing Activities: Amount of cash inflow from issuance of common stock at an equity offering, net of offering expenses. Proceeds From Issuance Of Common Stock, Net Of Issuance Costs At Equity Offering Proceeds from issuance of common shares, net of offering costs - equity offering Proceeds from issuance of common shares - At-the-Market Offering. Proceeds From Issuance of Common Shares - At-the-Market Offering Proceeds from issuance of common shares, net of offering costs - At-the-Market offering Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Net change in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash and cash equivalents, end of the period Cash and cash equivalents, beginning of the period Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosure of noncash activities: Stock Issued Issuance of common shares - Founders Agreement and equity fee to Fortress Unpaid offering costs for the issuance of equity offering. Unpaid Offering Costs For Issuance of Equity Offering Unpaid offering costs - equity offering Organization, Description of Business and Liquidity and Capital Resources Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Organization, Description of Business and Liquidity and Capital Resources Significant Accounting Policies Significant Accounting Policies [Text Block] Significant Accounting Policies Related Party Agreements Related Party Transaction [Table] Related Party Transaction [Line Items] Related Party Agreements Related Party Transactions Disclosure [Text Block] Related Party Agreements Accounts Payable and Accrued Expenses Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accounts Payable and Accrued Expenses Stockholders' Equity Equity [Text Block] Stockholders' Equity Net Loss per Share Earnings Per Share [Text Block] Net Loss per Share Income Taxes Deferred Tax Asset, Valuation Allowance [Table] Valuation Allowance [Line Items] Income Taxes Income Tax Disclosure [Text Block] Income Taxes Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Subsequent Events Subsequent Events [Text Block] Subsequent Events Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Use of Estimates, Policy [Policy Text Block] Use of Estimates Segment Reporting, Policy [Policy Text Block] Segment Reporting Disclosure of material changes to the company's significant accounting policies previously disclosed. Significant Accounting Policies [Policy Text Block] Significant Accounting Policies New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued Accounting Standards Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of Accounts Payable and Accrued Expenses Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Restricted Stock [Member] Unvested restricted stock awards Restricted stock award Restricted Stock Units (RSUs) [Member] Unvested restricted stock units Restricted stock units Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Stockholders' Equity Summary of warrant activities [Table Text Block] Summary of warrant activities [Table Text Block] Summary of Warrant Activities Share-Based Payment Arrangement, Option, Activity [Table Text Block] Summary of Stock Option Activities Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Schedules of Restricted Stock and Restricted Stock Unit Activity Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] Schedule of Stock-Based Compensation Expense Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Potentially Dilutive Securities Sale of Stock, Consideration Received on Transaction Net proceeds of offering Stockholders' Equity. Class of Stock [Line Items] Significant Accounting Policies Number of Operating Segments Number of operating segments Related and Nonrelated Parties [Axis] Related and Nonrelated Parties [Domain] Majority-Owned Subsidiary, Nonconsolidated [Member] Parent Company Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Management Services Agreement [Member]. Management Services Agreement [Member] Management Services Agreement (MSA) Second Amended and Restated Founders Agreement [Member]. Second Amended and Restated Founders Agreement [Member] Founders Agreement Counterparty Name [Axis] Counterparty Name [Domain] Fortress Biotech, Inc [Member] Fortress Biotech, Inc Percentage of annual fees expense related to Management Services Agreement recorded in research and development expenses Percentage of Annual Fees Expenses Related to Management Services Agreement recorded in research and development expenses Percentage of annual fees expense related to Management Services Agreement recorded in research and development expenses Percentage of annual fees expense related to Management Services Agreement recorded in general and administrative expenses Percentage of annual fees expense related to Management Services Agreement recorded in general and administrative expenses Percentage of annual fees expense related to Management Services Agreement recorded in general and administrative expenses Operating Costs and Expenses Expenses from related party transaction Represents the percentage of diluted outstanding equity paid as equity fee or used to calculate stock issuance to maintain parity. Diluted Outstanding Equity, Percentage Percentage of fully diluted equity Research and Development Asset Acquired in Transaction Other than Business Combination or Joint Venture Formation, Writeoff Research and development for expense acquired Presentation of information about accounts payable and accrued expenses. Accounts Payable and Accrued Expenses [Table] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Accounts Payable and Accrued Expenses [Line Items] Accounts Payable and Accrued Expenses Accounts Payable, Current Accounts payable Carrying value as of the balance sheet date of obligations incurred and payable for research and development. Research and Development Current Accrued research and development Carrying value as of the balance sheet date of obligations incurred through that date and payable for accrued compensation. Accrued Compensation Current Accrued compensation Other Accounts Payable and Accrued Liabilities Other Asset Acquisition [Axis] Asset Acquisition [Domain] Represents information pertaining to Asset Purchase Agreement with uBriGene (Boston) Biosciences, Inc. Asset Purchase Agreement with Ubrigene Biosciences [Member] Repurchase of Assets Amount of subsequent consideration recognized as part of consideration transferred in asset acquisition. Asset Acquisition, Consideration Transferred, Subsequent Payment Subsequent payment Amount of accrued interest on deferred purchase consideration arising from an asset acquisition. Asset Acquisition, Accrued Interest On Deferred Purchase Consideration Accrued interest Amount of upfront consideration recognized as part of consideration transferred in asset acquisition. Asset Acquisition, Consideration Transferred, Upfront Payment Upfront payment Represents the due period for deferred payment from Effective Date in an asset acquisition. Asset Acquisition, Consideration Transferred, Deferred Payment, Due Period from Closing Date Subsequent amount, due period from closing date Represents the extension term for delay in payment of deferred payment. Asset Acquisition, Consideration Transferred, Deferred Payment, Extension Term Extension term for deferred payment Amount of net assets below this threshold, then the Company may, upon written notice to uBriGene, elect to delay its payment obligation of the Deferred Amount by an additional six (6) months, with no limit on the number of such extensions available to the Company. Net Assets Threshold to Delay Consideration Payment Obligation Amount of net assets below this threshold, the Company may elect to delay payment obligation by additional six months Represents percentage of interest accrual on outstanding liability of deferred payment in asset acquisition transaction. Asset Acquisition, Consideration Transferred, Deferred Payment, Interest Rate on Outstanding Liability Interest rate on outstanding Deferred Amount Sale of Stock [Axis] Sale of Stock [Domain] Registration Statements [Member] Registration Statements [Member] Registration Statements Registration Statements, 2024 S-3 [Member] Registration Statements, 2024 S-3 [Member] 2024 S-3 Sale of Stock aggregate offering price permitted by agreement. Sale of Stock aggregate offering price permitted by agreement Sale of Stock aggregate offering price Common Stock Shares Available For Future Issuance Value Common Stock Shares Available For Future Issuance Value Shares available for future issuance Represents information pertaining to February 2025 Public offering. February 2025 Public Offering [Member] February 2025 Equity Offering Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Represents the information pertaining to prefunded warrants. Prefunded Warrants [Member] Pre-Funded Warrants Represents information pertaining to Series C1 warrant. Series C1 Warrant [Member] Series C-1 Warrants Represents information pertaining to Series C2 warrant. Series C2 Warrant [Member] Series C-2 Warrants Represents the information pertaining to series A-3 warrants. Series A3 Warrant [Member] Series A-3 warrant Represents the information pertaining to placement agents warrants. Placement Agents Warrants [Member] Placement Agents Warrants Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum [Member] Maximum Stock Issued During Period, Shares, New Issues Issuance of common shares (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrants issued Number of warrant or right may be converted. Class of Warrant Converted Number of warrant to converted Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Number of common stock, each warrant get converted Sale of Stock, Price Per Share Price per share Class of Warrant or Right, Exercise Price of Warrants or Rights Warrant exercise price (in dollars per share) Exercise price of warrant Warrants and Rights Outstanding, Term Warrants expiration term Class of Warrant or Right, Outstanding Warrants Outstanding, ending Warrants Outstanding, beginning Number of warrants outstanding The cash fee payable as a percentage of gross proceeds from the exercise of existing warrants. Cash Fee As percentage Of Aggregate Gross proceeds Cash fee as percentage of aggregate gross proceeds The management fee payable as a percentage of gross proceeds raised. Management Fee As Percentage Of Gross Proceeds Management fee as percentage of gross proceeds The fees associated with the services provided by the Placement Agent's counsel and other out of pocket expenses. Fees And Other Related Expenses Fees and expenses Amount of non-accountable expense allowance paid to placement agent. Non Accountable Expense Allowance Non accountable expense allowance Amount of organizing and conducting road shows by placement agent. Road Show Expenses Road show expenses Expenses associated with the clearing and settlement of securities transactions. Clearing Expenses Clearing expenses Percentage of shares and pre-funded warrants sold in the offering. Prefunded Warrant And Share Sold In Offering, Percentage Offering percentage sold Percentage of combined public offering price per share of common stock and accompanying Warrants. Combined Offering Price, Percentage Offering percentage Expiry term of warrants, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days Class of Warrant or Right, Expiry Term Termination of warrant Information pertaining to issuances of stock offered on an At The Market basis. At the Market Offering [Member] At the Market Offering Percentage of commission rate on gross sale of common stock. Commission Rate Percentage Agent commission (as a percent) Shares Issued, Price Per Share Price per common stock Proceeds from Issuance of Common Stock Proceeds from issuance of common shares Payments of Stock Issuance Costs Aggregate fees of stock issuance Class of Warrant or Right [Table] Class of Warrant or Right [Line Items] Stockholders' Equity The number of warrants or rights exercised and expired during the period. Class Of Warrant Or Right, Warrants Exercised And Expired During The Period Warrants Exercised/expired Warrant exercise price, expired during the period. Warrant Exercise Price Expired During Period Weighted Average Exercise Price, Expired (in dollars per share) The weighted average remaining contractual life for warrants outstanding. Class Of Warrant Or Right Weighted Average Remaining Contractual Life Warrants outstanding, remaining contractual life Employee Stock [Member] Employee Stock Purchase Plan Plan Name [Axis] Plan Name [Domain] Represents information pertaining to equity incentive plan. Equity Incentive Plan [Member] Incentive Plan Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Shares authorized Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Additional shares authorized Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Shares available for grant Common Stock, Capital Shares Reserved for Future Issuance Shares available for future sale Employee stock purchase plan, predetermined offering period, lower fair market value percentage. Employee Stock Purchase Plan, Predetermined Offering Period, Lower Fair Market Value Percentage Predetermined offering period, lower fair market value percentage Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Options rollforward Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Options, Outstanding, Number, Ending Balance Stock Options, Outstanding, Number, Beginning Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted Average Exercise Price, Ending Weighted Average Exercise Price, Beginning Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted Average Exercise Price, options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Life, Options outstanding (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Life, Options vested and exercisable (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Unrecognized share-based compensation Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Restricted stock and RSU rollforward Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Nonvested, Number, Ending Balance Nonvested, Number, Beginning Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Nonvested, Ending Balance Nonvested, Beginning Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Weighted average vesting period (in years) Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Domain] General and Administrative Expense [Member] General and administrative Research and Development Expense [Member] Research and development Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Warrant [Member] Warrants Antidilutive Securities Excluded from Computation of Earnings Per Share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Potentially dilutive securities The number of shares into which the stock may be converted. Convertible Stock, Number of Shares Upon Conversion Class A common stock and Class A preferred stock, rights to convert to number of common shares Lessee, Lease, Description [Table] Lessee, Lease, Description [Line Items] Commitments and Contingencies Gain (Loss) on Termination of Lease Gain on lease termination The cost incurred for the use of property or facilities, such as office space, equipment, or other leased assets, recognized as an expense during a reporting period. Rent Expense Rent expense